Artiva Biotherapeutics, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 11 →Insiders8 insiders bought $109.2M in 22 open-market buys. 5 insiders sold $1.9M, 6 of 15 sales on a 10b5-1 plan.→HoldersRa $174.2MViking Global Investors $25.3MBlackstone $23.3M→Financing →PeersClosest companies: JSPR, SNTI, FTCI→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$90.8Mlast 12 months
- Operating cash flow
- −$77.9Mlast 12 months
- Cash and equivalents
- $301.5Mat the last balance sheet
- Shares outstanding
- 424.0K shareson issue